© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Liquidia Corporation (LQDA) stock surged +1.83%, trading at $76.92 on NASDAQ, up from the previous close of $75.54. The stock opened at $74.80, fluctuating between $74.80 and $78.25 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 25, 2026 | 74.53 | 78.25 | 74.53 | 76.92 | 1.57M |
| Jun 24, 2026 | 73.99 | 76.35 | 72.22 | 75.54 | 2.09M |
| Jun 23, 2026 | 74.33 | 77.09 | 73.80 | 74.04 | 1.71M |
| Jun 22, 2026 | 72.97 | 76.66 | 71.77 | 75.49 | 2.91M |
| Jun 18, 2026 | 70.44 | 71.99 | 66.83 | 71.07 | 12.43M |
| Jun 17, 2026 | 67.28 | 70.20 | 67.28 | 68.65 | 1.71M |
| Jun 16, 2026 | 71.67 | 73.22 | 66.55 | 68.01 | 2.32M |
| Jun 15, 2026 | 72.61 | 72.61 | 68.56 | 71.80 | 2.1M |
| Jun 12, 2026 | 70.97 | 72.71 | 70.39 | 71.23 | 1.69M |
| Jun 11, 2026 | 66.65 | 72.49 | 66.32 | 71.63 | 3.32M |
| Jun 10, 2026 | 64.25 | 66.71 | 63.07 | 65.25 | 2.12M |
| Jun 09, 2026 | 64.60 | 65.95 | 61.72 | 64.01 | 1.62M |
| Jun 08, 2026 | 64.97 | 66.78 | 62.93 | 63.90 | 2.96M |
| Jun 05, 2026 | 62.76 | 65.99 | 61.39 | 61.85 | 1.69M |
| Jun 04, 2026 | 55.14 | 66.24 | 54.50 | 62.54 | 4.39M |
| Jun 03, 2026 | 55.26 | 56.42 | 53.06 | 55.69 | 1.34M |
| Jun 01, 2026 | 60.87 | 61.26 | 58.63 | 58.75 | 1.34M |
| May 29, 2026 | 61.50 | 62.30 | 60.66 | 61.86 | 1.28M |
| May 28, 2026 | 62.37 | 62.50 | 61.15 | 62.03 | 837.92K |
| May 27, 2026 | 59.60 | 63.46 | 59.37 | 62.03 | 1.35M |
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.
| Employees | 170 |
| Beta | 0.59 |
| Sales or Revenue | $17.49M |
| 5Y Sales Change% | -0.288% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |